The Rohatyn Group Completes Sale of 36.6% Huvepharma Stake to Advance Properties
Advance Properties OOD total shareholding in Bulgarian pharmaceuticals company Huvepharma AD is now 100% New York – November 20, 2014 – The Rohatyn Group (“TRG”), an independent investment firm focused on emerging markets, today announced that TRG Growth Fund II has finalised the sale of…
EM Private Markets, EMEA, News